Altre lingue Maxigen Biotech Inc.

Azioni

1783

TW0001783009

Prezzo di chiusura Taiwan S.E. Altri mercati azionari 00:00:00 15/07/2024			Variaz. 5gg	Var. 1 gen.
45,2 ^TWD	+0,56%		-3,83%	-6,61%

05/07	Maxigen Biotech Inc. annuncia un dividendo in azioni ordinarie, pagabile il 16 agosto 2024	CI
06/05	Maxigen Biotech Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Maxigen Biotech Inc. Announces Common Stock Dividend, Payable on August 16, 2024	05/07
Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	06/05
Maxigen Biotech Inc. Announces Cash Dividend for the Period from January 1, 2023 to December 31, 2023	03/05
Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Maxigen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11
Maxigen Biotech Inc.(TWSE:1783) added to S&P Global BMI Index	18/09/23
Maxigen Biotech Inc. Declares Dividend, Payable on October 12, 2023	23/08/23
Maxigen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	26/07/23
Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	09/05/23
Maxigen Biotech Inc. Announces Cash Dividend for the Period from January 1, 2022 to December 31, 2022	03/05/23
Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23
Maxigen Biotech Inc. Announces Executive Changes	22/03/23
Maxigen Biotech Inc. Reports Consolidated Revenues Results for the Month and Year to Date Ended December 2022	06/01/23
Maxigen Biotech Inc. Announces Resignation of You Wan-How as Financial Officer and Accounting Officer	29/12/22
Maxigen Biotech Inc. Reports Consolidated Revenues Results for the Month and Year to Date Ended November 2022	06/12/22
Maxigen Biotech Inc. Reports Consolidated Revenues Results for the Month and Year to Date Ended October 2022	07/11/22
Maxigen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	25/10/22
Maxigen Biotech Inc. Reports Consolidated Revenue Results for the Month and Year-To-Date Ended September 2022	05/10/22
Maxigen Biotech : Monthly revenue report, July 2022	09/08/22
Maxigen Biotech Inc. Reports Consolidated Revenue Results for the Month and Year-to-Date Ended July 2022	09/08/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Maxigen Biotech Inc.

Azioni

1783

TW0001783009

Altre lingue

Filtri